Skip to Main Content
DownloadHi-Res Photo

Laura Marie Nally, MD

Instructor; Assistant Professor, Pediatric Endocrinology & Diabetes

Contact Information

Laura Marie Nally, MD

Mailing Address

  • Pediatric Endocrinology & Diabetes

    1 Long Wharf Drive, Suite 503

    New Haven, CT 06511-5991

    United States

Yale Medicine

Patient Care

Are you a patient?Please visit the Yale Medicine website for information about the services we offer and making an appointment.View Doctor Profile

Research Summary

Since my diagnosis of type 1 diabetes at the age of 6, I have witnessed first-hand some of the most incredible technological advances in diabetes care. From the development of faster, more accurate glucometers, rapid acting insulin, insulin pump therapy, and continuous glucose monitoring systems, each of these new developments has greatly improved my quality of life.

Extensive Research Description

My current research involves studying how dietary factors affect glycemic control in type 1 diabetes. I am also interested in looking at psychosocial factors that affect chronic illness management, and using behavioral interventions to help adolescents cope with and manage type 1 diabetes. Further, with the rising out of pocket cost for diabetes medications, I am interested in evaluating how individuals successfully navigate our healthcare system and how we can potentially improve the healthcare system.

Coauthors

Selected Publications

  • Technology Utilization in Black Adolescents with Type 1 Diabetes: Exploring the Decision-Making Process.Mencher SR, Weinzimer SA, Nally LM, Van Name M, Nunez-Smith M, Sadler LS. Technology Utilization in Black Adolescents with Type 1 Diabetes: Exploring the Decision-Making Process. Diabetes Technology & Therapeutics 2022, 24: 249-257. PMID: 35085444, DOI: 10.1089/dia.2021.0413.
  • Case Report: Managing Pregnancy With Type 1 Diabetes Using a Do-It-Yourself Artificial Pancreas System.Waikar AR, Arora T, Haynes M, Tamborlane WV, Nally LM. Case Report: Managing Pregnancy With Type 1 Diabetes Using a Do-It-Yourself Artificial Pancreas System. Clinical Diabetes : A Publication Of The American Diabetes Association 2021, 39: 441-444. PMID: 34866788, PMCID: PMC8603326, DOI: 10.2337/cd20-0128.
  • Open-Source Automated Insulin DeliveryCommentary "Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals"
  • The Influence of Health Mindset on Perceptions of Illness and Behaviors Among Adolescents.John-Henderson NA, Wright RC, Manke KJ, Fotuhi O, Zuckerman B, Nally L, Mueller CM. The Influence of Health Mindset on Perceptions of Illness and Behaviors Among Adolescents. International Journal Of Behavioral Medicine 2021, 28: 727-736. PMID: 33721232, DOI: 10.1007/s12529-021-09972-2.
  • A Pilot Study of Youth With Type 1 Diabetes Initiating Use of a Hybrid Closed-Loop System While Receiving a Behavioral Economics Intervention.Nally LM, Wagner J, Sherr J, Tichy E, Weyman K, Ginley MK, Zajac K, Desousa M, Shabanova V, Petry NM, Tamborlane WV, Van Name M. A Pilot Study of Youth With Type 1 Diabetes Initiating Use of a Hybrid Closed-Loop System While Receiving a Behavioral Economics Intervention. Endocrine Practice : Official Journal Of The American College Of Endocrinology And The American Association Of Clinical Endocrinologists 2021, 27: 545-551. PMID: 34120699, PMCID: PMC8206518, DOI: 10.1016/j.eprac.2020.11.017.
  • Establishing a Global Standard for Wearable Devices in Sport and Exercise Medicine: Perspectives from Academic and Industry Stakeholders.Ash GI, Stults-Kolehmainen M, Busa MA, Gaffey AE, Angeloudis K, Muniz-Pardos B, Gregory R, Huggins RA, Redeker NS, Weinzimer SA, Grieco LA, Lyden K, Megally E, Vogiatzis I, Scher L, Zhu X, Baker JS, Brandt C, Businelle MS, Fucito LM, Griggs S, Jarrin R, Mortazavi BJ, Prioleau T, Roberts W, Spanakis EK, Nally LM, Debruyne A, Bachl N, Pigozzi F, Halabchi F, Ramagole DA, Janse van Rensburg DC, Wolfarth B, Fossati C, Rozenstoka S, Tanisawa K, Börjesson M, Casajus JA, Gonzalez-Aguero A, Zelenkova I, Swart J, Gursoy G, Meyerson W, Liu J, Greenbaum D, Pitsiladis YP, Gerstein MB. Establishing a Global Standard for Wearable Devices in Sport and Exercise Medicine: Perspectives from Academic and Industry Stakeholders. Sports Medicine (Auckland, N.Z.) 2021, 51: 2237-2250. PMID: 34468950, PMCID: PMC8666971, DOI: 10.1007/s40279-021-01543-5.
  • Plasmapheresis as an Early Treatment for Severe Hypertriglyceridemia, Acute Pancreatitis, and Diabetic Ketoacidosis.Kravetz AM, Sanghavi P, Bhargava V, Shi RZ, Nally LM. Plasmapheresis as an Early Treatment for Severe Hypertriglyceridemia, Acute Pancreatitis, and Diabetic Ketoacidosis. AACE Clinical Case Reports 2021, 7: 315-319. PMID: 34522772, PMCID: PMC8426612, DOI: 10.1016/j.aace.2021.03.009.
  • The dawn of automated insulin delivery: from promise to product8. Nally, LM, Sherr, JL. (2020) “Chapter 16. The Dawn of Automated Insulin Delivery: From Promise to Product.” In Fabris (Ed.), Glucose Monitoring Devices: Measuring Blood Glucose to Manage and Control Diabetes (pp.237-356). Philadelphia, PA: Elsevier.
  • Expensive Insulin-The Epicenter of a Large, Life-Threatening Problem.Nally LM, Lipska KJ. Expensive Insulin-The Epicenter of a Large, Life-Threatening Problem. JAMA Internal Medicine 2020, 180: 931-933. PMID: 32478822, DOI: 10.1001/jamainternmed.2020.1299.
  • Pharmacologic treatment options for type 1 diabetes: what's new?Nally LM, Sherr JL, Van Name MA, Patel AD, Tamborlane WV. Pharmacologic treatment options for type 1 diabetes: what's new? Expert Review Of Clinical Pharmacology 2019, 12: 471-479. PMID: 30892094, PMCID: PMC6488361, DOI: 10.1080/17512433.2019.1597705.
  • A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring.Nally LM, Bondy N, Doiev J, Buckingham BA, Wilson DM. A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring. Diabetes Technology & Therapeutics 2019, 21: 170-176. PMID: 30839229, DOI: 10.1089/dia.2018.0337.
  • Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting.Ekhlaspour L, Nally LM, El-Khatib FH, Ly TT, Clinton P, Frank E, Tanenbaum ML, Hanes SJ, Selagamsetty RR, Hood K, Damiano ER, Buckingham BA. Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting. Journal Of Diabetes Science And Technology 2019, 13: 1001-1007. PMID: 31470740, PMCID: PMC6835195, DOI: 10.1177/1932296819872225.
  • Wilderness Medical Society Clinical Practice Guidelines for Diabetes Management.VanBaak KD, Nally LM, Finigan RT, Jurkiewicz CL, Burnier AM, Conrad BP, Khodaee M, Lipman GS. Wilderness Medical Society Clinical Practice Guidelines for Diabetes Management. Wilderness & Environmental Medicine 2019, 30: S121-S140. PMID: 31753543, PMCID: PMC7510348, DOI: 10.1016/j.wem.2019.10.003.
  • Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice.Li R, Buras E, Lee J, Liu R, Liu V, Espiritu C, Ozer K, Thompson B, Nally L, Yuan G, Oka K, Chang B, Samson S, Yechoor V, Chan L. Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice. Gene Therapy 2015, 22: 876-82. PMID: 26172077, PMCID: PMC4636470, DOI: 10.1038/gt.2015.62.

Clinical Trials

ConditionsStudy Title
Diabetes Mellitus - Type 1Virtual Physical Activity for Type 1 Diabetes
Children's Health; Diabetes Mellitus - Type 1Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System
Diabetes Mellitus - Type 1The Effect of Bolus Speed of Rapid-Acting Insulin Analog Absorption and Action in Individuals With Type 1 Diabetes
Edit Profile